Lili Ji

1.1k total citations
32 papers, 841 citations indexed

About

Lili Ji is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lili Ji has authored 32 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Lili Ji's work include Genomics, phytochemicals, and oxidative stress (8 papers), RNA modifications and cancer (6 papers) and Glutathione Transferases and Polymorphisms (5 papers). Lili Ji is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (8 papers), RNA modifications and cancer (6 papers) and Glutathione Transferases and Polymorphisms (5 papers). Lili Ji collaborates with scholars based in China, United States and Canada. Lili Ji's co-authors include Tao Jiang, Junyan Liu, Dingqiang Chen, Yang Deng, Guangchao Yu, Lei Chen, Xuerui Bao, Jian Miao, Yanmei Li and Pan Gao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Lili Ji

31 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lili Ji China 14 460 215 127 125 104 32 841
Helena Ramos Portugal 17 385 0.8× 295 1.4× 131 1.0× 72 0.6× 174 1.7× 38 863
Jung‐Hee Kim South Korea 18 410 0.9× 93 0.4× 165 1.3× 59 0.5× 57 0.5× 35 739
Maria Visalli Italy 24 765 1.7× 375 1.7× 160 1.3× 108 0.9× 116 1.1× 49 1.6k
Alejandro A. Hidalgo Chile 15 240 0.5× 117 0.5× 43 0.3× 47 0.4× 57 0.5× 37 711
Hongchao Zhou China 15 294 0.6× 77 0.4× 108 0.9× 57 0.5× 88 0.8× 34 933
Junjing Jia China 15 468 1.0× 74 0.3× 85 0.7× 84 0.7× 156 1.5× 43 1.1k
Hong Huang China 16 466 1.0× 119 0.6× 62 0.5× 40 0.3× 83 0.8× 35 899
Haibao Zhang China 18 726 1.6× 63 0.3× 129 1.0× 19 0.2× 68 0.7× 36 1.2k
Xiaofei Zhang China 13 344 0.7× 91 0.4× 223 1.8× 48 0.4× 143 1.4× 32 660

Countries citing papers authored by Lili Ji

Since Specialization
Citations

This map shows the geographic impact of Lili Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Ji more than expected).

Fields of papers citing papers by Lili Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Ji. The network helps show where Lili Ji may publish in the future.

Co-authorship network of co-authors of Lili Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Lili Ji. A scholar is included among the top collaborators of Lili Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lili Ji. Lili Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jiaxin, Lili Ji, Shaohong Zang, et al.. (2025). Algal carbon quantum dots/Bi2MoO6 S-scheme heterojunction with enhanced visible-light photocatalytic degradation for ciprofloxacin. Separation and Purification Technology. 363. 132196–132196. 7 indexed citations
2.
Xu, Yi, et al.. (2025). Interplay between Nrf2 and ROS in regulating epithelial-mesenchymal transition: implications for cancer metastasis and therapy. Molecular Biology Reports. 52(1). 628–628. 1 indexed citations
3.
Huang, Zhenlin, Shaobo Zhang, Shangfu Xu, et al.. (2025). TSG attenuated NAFLD and facilitated weight loss in HFD-fed mice via activating the RUNX1/FGF21 signaling axis. Acta Pharmacologica Sinica. 46(10). 2723–2733.
4.
Zuo, Ling, Jia Ge, Rui Chen, et al.. (2025). The Nrf2-HMOX1 pathway as a therapeutic target for reversing cisplatin resistance in non-small cell lung cancer via inhibiting ferroptosis. Cell Death Discovery. 11(1). 287–287. 2 indexed citations
5.
Tu, Shuangshuang, Liangxue Lai, Yannan Yuan, et al.. (2024). Mild phototherapy mediated by IR780-Gd-OPN nanomicelles suppresses atherosclerotic plaque progression through the activation of the HSP27-regulated NF-κB pathway. Acta Biomaterialia. 182. 199–212. 2 indexed citations
6.
Cai, Xiaorong, Shaohong Zang, Lili Ji, et al.. (2024). S-scheme heterojunction of CoMoO4/PCN with lower overpotential for photocatalytic water oxidation. Separation and Purification Technology. 354. 129146–129146. 6 indexed citations
7.
Ji, Lili, et al.. (2022). NRF2信号通路促进非小细胞肺癌增殖的研究进展. SHILAP Revista de lepidopterología. 3 indexed citations
8.
Ji, Lili, Rui Zhang, Jie Chen, et al.. (2019). PIDD interaction with KEAP1 as a new mutation-independent mechanism to promote NRF2 stabilization and chemoresistance in NSCLC. Scientific Reports. 9(1). 12437–12437. 14 indexed citations
9.
Tang, Jie, Lili Ji, Yuchan Wang, et al.. (2015). Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells. International Journal of Hematology. 102(1). 25–34. 8 indexed citations
10.
11.
Yang, Lei, Junya Zhu, Jian‐Guo Zhang, et al.. (2015). Far upstream element-binding protein 1 (FUBP1) is a potential c-Myc regulator in esophageal squamous cell carcinoma (ESCC) and its expression promotes ESCC progression. Tumor Biology. 37(3). 4115–4126. 26 indexed citations
12.
Chen, Jie, Jun Gu, Jian Feng, et al.. (2015). TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway. Tumor Biology. 37(3). 3851–3861. 13 indexed citations
13.
Ni, Tingting, Guoxin Mao, Qun Xue, et al.. (2015). Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis. Journal of Molecular Histology. 46(4-5). 325–335. 34 indexed citations
14.
Ji, Lili, Yingze Wei, Tao Jiang, & Shuyang Wang. (2014). Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival.. PubMed. 7(3). 1124–31. 60 indexed citations
15.
He, Song, Yuejiao Huang, Yuchan Wang, et al.. (2014). Histamine-releasing factor/translationally controlled tumor protein plays a role in induced cell adhesion, apoptosis resistance and chemoresistance in non-Hodgkin lymphomas. Leukemia & lymphoma. 56(7). 2153–2161. 4 indexed citations
16.
Xia, Cong, Lili Ji, Xiaopeng Cui, et al.. (2014). Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma. Pathology - Research and Practice. 210(11). 719–725. 5 indexed citations
17.
Ji, Lili, Tingting Ni, Qun Xue, et al.. (2014). Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation. Journal of Molecular Histology. 45(5). 573–582. 19 indexed citations
18.
Zhu, Junya, Lili Ji, Jianguo Zhang, et al.. (2014). Upregulation of SYF2 in esophageal squamous cell carcinoma promotes tumor cell proliferation and predicts poor prognosis. Tumor Biology. 35(10). 10275–10285. 5 indexed citations
19.
Gao, Pan, Liliang Li, Lili Ji, et al.. (2014). Nrf2 ameliorates diabetic nephropathy progression by transcriptional repression of TGFβ1 through interactions with c-Jun and SP1. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1839(11). 1110–1120. 43 indexed citations
20.
Ji, Lili, Hui Li, Pan Gao, et al.. (2013). Nrf2 Pathway Regulates Multidrug-Resistance-Associated Protein 1 in Small Cell Lung Cancer. PLoS ONE. 8(5). e63404–e63404. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026